FR2118134B1 - - Google Patents

Info

Publication number
FR2118134B1
FR2118134B1 FR7145283A FR7145283A FR2118134B1 FR 2118134 B1 FR2118134 B1 FR 2118134B1 FR 7145283 A FR7145283 A FR 7145283A FR 7145283 A FR7145283 A FR 7145283A FR 2118134 B1 FR2118134 B1 FR 2118134B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7145283A
Other languages
French (fr)
Other versions
FR2118134A1 (en
Inventor
Victor Assad Najjar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of FR2118134A1 publication Critical patent/FR2118134A1/fr
Application granted granted Critical
Publication of FR2118134B1 publication Critical patent/FR2118134B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7145283A 1970-12-16 1971-12-16 Expired FR2118134B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9889070A 1970-12-16 1970-12-16

Publications (2)

Publication Number Publication Date
FR2118134A1 FR2118134A1 (en) 1972-07-28
FR2118134B1 true FR2118134B1 (en) 1975-10-10

Family

ID=22271422

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7145283A Expired FR2118134B1 (en) 1970-12-16 1971-12-16

Country Status (7)

Country Link
US (1) US3778426A (en)
JP (1) JPS6053040B1 (en)
CA (1) CA999851A (en)
CH (1) CH605672A5 (en)
DE (1) DE2124003C2 (en)
FR (1) FR2118134B1 (en)
GB (1) GB1364497A (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
US4073890A (en) * 1974-03-26 1978-02-14 Takeda Chemical Industries, Ltd. Novel polypeptides
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
SE407058B (en) * 1974-12-05 1979-03-12 Kabi Ab NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES
DE2602443A1 (en) * 1975-04-04 1976-10-21 Univ California BIOLOGICALLY ACTIVE POLYPEPTIDES
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
US4169015A (en) * 1975-07-11 1979-09-25 Ab Kabi Novel chromogenic thrombin substrates
US4181717A (en) * 1978-09-07 1980-01-01 Research Corporation Ovulation enhancing peptides
IT8021120A0 (en) 1979-04-02 1980-04-01 Inst Organicheskogo Sinteza Ak CYCLIC ANALOGUE OF THE NATURAL PEPTIDE THAT STIMULATES PHAGOCYTOSIS: THREONYL-CYCLE (N-LYSYL-PROLYL-ARGINYL).
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4752601A (en) * 1983-08-12 1988-06-21 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin FC receptors
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
IT1188646B (en) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica TRIPEPTIDE WITH IMMUNOSTIMULANT ACTIVITY
GB8807427D0 (en) * 1988-03-28 1988-05-05 National Biological Standards Board Peptides
JP2633369B2 (en) * 1988-03-28 1997-07-23 ブリティッシュ・テクノロジー・グループ・リミテッド peptide
IT1230712B (en) * 1989-02-10 1991-10-29 Sclavo Spa COMPOSITION FOR VACCINES
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
IT1232311B (en) * 1989-09-04 1992-01-28 Sclavo Spa PURIFICATION METHOD OF LOW MOLECULAR PEPTIDIC OR PSEUDO PEPTIDIC STRUCTURE COMPOUNDS.
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
HUP0500995A3 (en) * 2001-08-30 2008-09-29 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof in therapy
WO2009033792A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
RU2507212C3 (en) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE
CN104662034B (en) * 2013-05-28 2021-05-11 "Ivix"有限公司 Method for producing recombinant peptides and resulting peptides
RU2626002C1 (en) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" New group of peptides for treatment of female sexual dysfunction
JP2018118973A (en) * 2018-02-23 2018-08-02 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． Method for producing recombinant peptide and resultant peptide

Also Published As

Publication number Publication date
DE2124003C2 (en) 1982-04-22
FR2118134A1 (en) 1972-07-28
GB1364497A (en) 1974-08-21
DE2124003A1 (en) 1972-06-22
CA999851A (en) 1976-11-16
JPS6053040B1 (en) 1985-11-22
CH605672A5 (en) 1978-10-13
US3778426A (en) 1973-12-11

Similar Documents

Publication Publication Date Title
FR2118134B1 (en)
JPS4910865B1 (en)
AU1146470A (en)
AU1473870A (en)
AU1336970A (en)
AU1716970A (en)
AU2017870A (en)
AU1517670A (en)
AU1326870A (en)
AU1833270A (en)
AU1943370A (en)
AU1083170A (en)
AU1603270A (en)
AU1343870A (en)
AU1872870A (en)
AU1879170A (en)
AU1328670A (en)
AU2130770A (en)
AU1881070A (en)
AU1918570A (en)
AU2119370A (en)
AU1277070A (en)
AU1689770A (en)
AU2130570A (en)
AU1247570A (en)

Legal Events

Date Code Title Description
ST Notification of lapse